<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05077020</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL21_0556</org_study_id>
    <nct_id>NCT05077020</nct_id>
  </id_info>
  <brief_title>Somatic Diseases in Autistic Children</brief_title>
  <acronym>SDA</acronym>
  <official_title>Medical Monitoring and Somatic Diseases in Children Who Suffer From Autism Spectrum Disorder (ASD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      For many reasons, medical monitoring in autistic patients is very difficult. This study is&#xD;
      designed to determine the prevalence of comorbid diseases (neurological, cardiac, digestive,&#xD;
      dental diseases…) in patients suffering from ASD to prevent them or diagnose them earlier.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Mean goal : to determine the prevalence of comorbid diseases (neurological, cardiac,&#xD;
      digestive, dental diseases…) in patients suffering from ASD to prevent them or diagnose them&#xD;
      earlier.&#xD;
&#xD;
      Secondary goals :&#xD;
&#xD;
        -  to obtain an objective assessment of the &quot;general&quot; monitoring in these patients&#xD;
           (vaccinations, growth…)&#xD;
&#xD;
        -  to assess their habits (food, sleep, screen exposition)&#xD;
&#xD;
        -  to determine, in this monitoring and the habits, vigilance points which will need a&#xD;
           specific pediatric consultation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Actual">October 1, 2021</completion_date>
  <primary_completion_date type="Actual">January 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Determine the prevalence of comorbid diseases</measure>
    <time_frame>1 day</time_frame>
    <description>Determine the prevalence of comorbid diseases</description>
  </primary_outcome>
  <enrollment type="Actual">27</enrollment>
  <condition>Autistic Spectrum Disorder</condition>
  <condition>Somatic Disorders</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Children followed by psychiatrists in Montpellier university hospital refered to a somatic&#xD;
        pediatrician&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
        - consultation after psychiatric evaluation&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  age &gt; 18 years&#xD;
&#xD;
          -  Impossibility to obtain the consent of parents / legal representatives.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric JEZIORSKI</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uhmontpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 11, 2021</study_first_submitted>
  <study_first_submitted_qc>October 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 13, 2021</study_first_posted>
  <last_update_submitted>October 18, 2021</last_update_submitted>
  <last_update_submitted_qc>October 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Autistic Disorder</mesh_term>
    <mesh_term>Autism Spectrum Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

